CRISPR Therapeutics
CRSP
#3304
Rank
A$5.25 B
Marketcap
$60.81
Share price
0.86%
Change (1 day)
-30.05%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$7.99

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$8.29. In 2022 the company made an earnings per share (EPS) of -$13.09 a decrease over its 2021 EPS that were of $7.81.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.99-38.99%
2022-$13.09-267.74%
2021$7.81-194.33%
2020-$8.28-576.58%
2019$1.74-132.36%
2018-$5.37100.58%
2017-$2.68159.42%
2016-$1.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.41-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA